CorMedix, Inc. (CRMD)

11.98 -0.41 (-3.31%) USD  |  NASDAQ  |  Dec 23, 16:00
12.01 +0.03 (+0.25%) Pre-Market: 08:54
More

CorMedix SG&A Expense (TTM): 75.56M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for CRMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Pfizer Inc. 13.91B
Arcutis Biotherapeutics, Inc. 253.18M
ANI Pharmaceuticals, Inc. 304.67M
Alkermes Plc 661.32M
Castle Biosciences, Inc. 222.56M